Your browser doesn't support javascript.
loading
CANDIED: A Pan-Canadian Cohort of Immune Checkpoint Inhibitor-Induced Insulin-Dependent Diabetes Mellitus.
Muniz, Thiago P; Araujo, Daniel V; Savage, Kerry J; Cheng, Tina; Saha, Moumita; Song, Xinni; Gill, Sabrina; Monzon, Jose G; Grenier, Debjani; Genta, Sofia; Allen, Michael J; Arteaga, Diana P; Saibil, Samuel D; Butler, Marcus O; Spreafico, Anna; Hogg, David.
Afiliação
  • Muniz TP; Division of Medical Oncology and Hematology, Princess Margaret Cancer Centre, University of Toronto, University Health Network, Toronto, ON M5S 1Z5, Canada.
  • Araujo DV; Hospital de Base, Faculdade de Medicina de Sao Jose do Rio Preto, Sao Jose do Rio Preto 15090-000, Brazil.
  • Savage KJ; Division of Medical Oncology, Department of Medicine, The University of British Columbia, Vancouver, BC V5Z 1M9, Canada.
  • Cheng T; Department of Oncology, University of Calgary, Calgary, AB T2N 4N2, Canada.
  • Saha M; Division of Endocrinology and Metabolism, University of British Columbia, Vancouver, BC V6Z 1Y6, Canada.
  • Song X; The Ottawa Hospital Cancer Centre, University of Ottawa, Ottawa, ON K1H 8L6, Canada.
  • Gill S; Division of Endocrinology and Metabolism, University of British Columbia, Vancouver, BC V6Z 1Y6, Canada.
  • Monzon JG; Department of Oncology, University of Calgary, Calgary, AB T2N 4N2, Canada.
  • Grenier D; Department of Medical Oncology, University of Manitoba, Winnipeg, MB R3A 1R9, Canada.
  • Genta S; Division of Medical Oncology and Hematology, Princess Margaret Cancer Centre, University of Toronto, University Health Network, Toronto, ON M5S 1Z5, Canada.
  • Allen MJ; Division of Medical Oncology and Hematology, Princess Margaret Cancer Centre, University of Toronto, University Health Network, Toronto, ON M5S 1Z5, Canada.
  • Arteaga DP; Division of Medical Oncology and Hematology, Princess Margaret Cancer Centre, University of Toronto, University Health Network, Toronto, ON M5S 1Z5, Canada.
  • Saibil SD; Division of Medical Oncology and Hematology, Princess Margaret Cancer Centre, University of Toronto, University Health Network, Toronto, ON M5S 1Z5, Canada.
  • Butler MO; Division of Medical Oncology and Hematology, Princess Margaret Cancer Centre, University of Toronto, University Health Network, Toronto, ON M5S 1Z5, Canada.
  • Spreafico A; Division of Medical Oncology and Hematology, Princess Margaret Cancer Centre, University of Toronto, University Health Network, Toronto, ON M5S 1Z5, Canada.
  • Hogg D; Division of Medical Oncology and Hematology, Princess Margaret Cancer Centre, University of Toronto, University Health Network, Toronto, ON M5S 1Z5, Canada.
Cancers (Basel) ; 14(1)2021 Dec 24.
Article em En | MEDLINE | ID: mdl-35008256
Palavras-chave
Texto completo
Imprimir
XML
PubMed Links
Buscar no Google

Texto completo: 1 Coleções: 01-internacional Base de dados: MEDLINE Tipo de estudo: Observational_studies / Prognostic_studies / Risk_factors_studies Idioma: En Revista: Cancers (Basel) Ano de publicação: 2021 Tipo de documento: Article País de afiliação: Canadá
Texto completo
Imprimir
XML
PubMed Links
Buscar no Google

Texto completo: 1 Coleções: 01-internacional Base de dados: MEDLINE Tipo de estudo: Observational_studies / Prognostic_studies / Risk_factors_studies Idioma: En Revista: Cancers (Basel) Ano de publicação: 2021 Tipo de documento: Article País de afiliação: Canadá